about
Hearing Restoration in Neurofibromatosis Type II PatientsA murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formationSecreted Factors from Human Vestibular Schwannomas Can Cause Cochlear Damage.Progress of hearing loss in neurofibromatosis type 2: implications for future management.Extracellular vesicles derived from human vestibular schwannomas associated with poor hearing damage cochlear cells.Hearing optimisation in neurofibromatosis type 2: A systematic review.Internal Auditory Canal Decompression for Hearing Maintenance in Neurofibromatosis Type 2 Patients.An allograft mouse model for the study of hearing loss secondary to vestibular schwannoma growth.Audiologic Natural History of Small Volume Cochleovestibular Schwannomas in Neurofibromatosis Type 2.Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models.Factors affecting hearing deterioration in vestibular schwannoma patients treated with gamma knife radiosurgery: the Asan Medical Center experience.Audiovestibular Characteristics of Small Cochleovestibular Schwannomas in Neurofibromatosis Type 2.Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma.CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.
P2860
Q26748852-C3482DE4-60F8-4810-89D0-B8C443F43951Q27301307-E5EBFF90-A428-4FE4-A327-75494B1C1E6DQ27303070-C134C58A-5C1C-493A-AB0E-9EC81E13DDC9Q38258002-4757A830-4ABB-4565-A593-9FFFFE143392Q38770088-51D46FF0-4D7F-498E-933F-0FC2543E186AQ38858820-4AFC0D3E-596F-443D-A9DA-37EF976C529CQ38941600-7FC27AEF-C211-4FC5-9FE6-26C901AE2130Q44526324-69478AEA-5A3A-485D-BE35-3BC3B2E27F31Q50002248-119556FC-CFDD-470C-ADCB-E18E0A8C4A2DQ50026654-2A03B1A4-8169-4E7F-A163-D5DFB1E9AB77Q50083444-6FF03035-4490-4F02-B858-0D99E68C56AEQ50425702-C022F032-3E41-4A2C-8514-5485DED6C4A4Q52608968-6A02A9F5-71C7-4FA1-9B84-98313FA62D18Q55638662-14175F68-3D07-4A50-AFF3-2425CA8ECE9A
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Mechanisms of hearing loss in neurofibromatosis type 2.
@ast
Mechanisms of hearing loss in neurofibromatosis type 2.
@en
type
label
Mechanisms of hearing loss in neurofibromatosis type 2.
@ast
Mechanisms of hearing loss in neurofibromatosis type 2.
@en
prefLabel
Mechanisms of hearing loss in neurofibromatosis type 2.
@ast
Mechanisms of hearing loss in neurofibromatosis type 2.
@en
P2093
P2860
P1433
P1476
Mechanisms of hearing loss in neurofibromatosis type 2.
@en
P2093
Ashok R Asthagiri
Carmen C Brewer
Chris Zalewski
H Jeffrey Kim
Keaton Morgan
Kelly King
Raul A Vasquez
Russell R Lonser
Tianxia Wu
P2860
P304
P356
10.1371/JOURNAL.PONE.0046132
P407
P577
2012-09-26T00:00:00Z